Immediate Impact
4 from Science/Nature 51 standout
Citing Papers
Click Chemistry in Proteomic Investigations
2020 Standout
PARP and PARG inhibitors in cancer treatment
2020 Standout
Works of S. B. Kaye being referenced
First-in-human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers (soc).
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. B. Kaye | 193 | 116 | 50 | 91 | 18 | 368 | |
| L. Dreyer | 56 | 67 | 39 | 55 | 21 | 325 | |
| Najla Al-Harbi | 94 | 78 | 8 | 162 | 24 | 404 | |
| Choonhee Son | 142 | 79 | 20 | 47 | 21 | 328 | |
| Daiki Ogishima | 30 | 43 | 155 | 67 | 26 | 381 | |
| S Yasuoka | 36 | 68 | 4 | 67 | 23 | 367 | |
| Cheng‐Cheng Hwang | 81 | 67 | 2 | 104 | 21 | 345 | |
| Nikolai Rachmaninoff | 79 | 104 | 10 | 19 | 17 | 337 | |
| Kabeer Shah | 78 | 67 | 2 | 43 | 20 | 382 | |
| Diane Mullins | 111 | 34 | 7 | 30 | 15 | 332 | |
| N W Derias | 110 | 66 | 6 | 75 | 22 | 403 |
All Works
Loading papers...